The infectious disease diagnostics market is expected to grow at a CAGR of 6.9% from 2020 to 2027 to reach at $42.85 billion by 2027. The epidemiological burden of infectious diseases like severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), Ebola, chikungunya, avian flu, swine flu, and Zika has opened door for their early diagnosis & prevention. Similarly, current outbreak of COVID-19 pandemic has tremendously increased the demand for various POC diagnostic kits for early diagnosis and control the spread of coronavirus. Further, the growing awareness for early detection using specific diagnostic tests, growth in funding for research on infectious disease diagnostics, and shift in focus from centralized laboratories to decentralized point-of-care testing services are expected to propel the growth of the global infectious disease diagnostics market. However, unfavorable and inadequate reimbursement scenario is expected to hamper the growth of the infectious disease diagnostics market.
Click Here: To Get Your Free Sample Report Now
Impact of COVID-19 on Infectious Disease Diagnostics Market
The rising burden of infectious diseases and hospital acquired infections across the globe has increased the demand for infectious disease diagnostics products. Recent outbreak of the coronavirus disease (COVID-19) which has emerged since November 2019 in Wuhan, China has created destruction in several countries across the world. According to the WHO, as of 28th April 2020, there were 3,073,603 confirmed cases, 2,11,768 confirmed deaths which has increased to 4,962,707 confirmed cases and 3,26,459 deaths worldwide as of 22nd May 2020. In this global pandemic, although many dedicated healthcare professionals work tirelessly on the frontlines to fight against this crisis, it’s equally important to minimize the spread of disease by early diagnosis. Since its outbreak in November 2019, the disease has spread to many countries around the globe with the World Health Organization declaring it a public health emergency.
Testing is one of the greatest tools in understanding and managing the coronavirus pandemic. In response to the growing COVID-19 pandemic and shortages of laboratory-based molecular testing capacity and reagents, multiple diagnostic test manufacturers have developed and begun selling rapid and easy-to-use devices to facilitate testing outside of laboratory settings. These simple test kits are based either on detection of proteins from the COVID-19 virus in respiratory samples (e.g. sputum, throat swab) or detection, in blood or serum, of human antibodies generated in response to infection. Organizations around the world, including the Forum and its partners, are coming together and innovating to minimize the impact on public health and to limit disruptions to economies and supply chains. Some of the key initiatives undertaken by the manufacturers and organizations are as follows:
Shift in focus from centralized laboratories to decentralized point-of-care services to propel the growth of the infectious disease diagnostics market
Molecular diagnostics has been done in centralized laboratories since many years, however, its few drawbacks like delay in results, high cost of tests, less accuracy, and late disease diagnosis have led to continuous shift in decentralizing clinical laboratory testing for infectious disease diagnosis. Point-of-care (POC) testing is majorly performed for the diagnosis purpose at or near the site where a patient initially encounters the health care system. POC tests have the potential to improve the patient management of infectious diseases. POC tests for various infectious diseases such as Chlamydia, gonorrhea, and influenza, among others, helps in providing early diagnosis and treatment. POC testing in the decentralized set up help the patient and the physicians to monitor the infectious diseases and improve the clinical workflow. In addition, improvement in the information technology contributed significantly in the process of decentralization of clinical laboratory testing.
Thus, the shift towards point of care testing is expected to accelerate the growth of the global infectious disease diagnostics market.
Key Findings in the Global Infectious Disease Diagnostics Market Study:
Immunodiagnostics segment to dominate the infectious disease diagnostics market in 2020
Based on technology, the immunodiagnostics segment is estimated to dominate the overall infectious disease diagnostics market in 2020. The dominance of this segment is mainly attributed to factors such as the Increasing use of immunoassays in infectious disease testing, development of novel tests, rising trend of automation, increasing awareness about health and fitness, and reduced complications associated with the instruments.
Based on products & solution, consumables segment to grow at the fastest CAGR during the forecast period
Based on products and services, the consumables segment is estimated to grow with the fastest CAGR during the forecast period, which is mainly attributed to the factors such as increasing prevalence of infectious diseases, rising awareness among the population to identify the diseases, and increasing use of kits and reagents to identify the organism causing various diseases in lesser time and cost. Further, the outbreak of coronavirus (COVID-19) disease since November 2019 is further expected to accelerate the growth of this segment owing to the national emergency declared and requirement of various kits and assays for early disease detection.
Hepatitis diseases to hold the largest share of the infectious disease diagnostics market in 2020
Based on diseases type, the hepatitis diseases segment is estimated to hold the largest share of the overall infectious disease diagnostics market in 2020. Increasing number of blood transfusions and donations, increasing prevalence of hepatitis B & C infections, rising susceptibility of the geriatric population, growing awareness among the population, and benefits offered by point of care instruments & kits are expected to propel the growth of this segment.
Asia Pacific: The fastest-growing market
At regional level, infectious disease diagnostics market is expected to be dominated by North America in 2020, while, Asia Pacific region is expected to grow at the fastest CAGR during the forecast period. The factors driving the growth of Asia Pacific infectious disease diagnostics market are rapid urbanization, increasing investments by healthcare providers towards infrastructure improvement, need to manage growing burden of infectious diseases, and government efforts to improve accessibility of diagnostic services to enhance the prevention by developing products or platforms required for the diagnosis of infectious diseases.
Key Players
The report includes competitive landscape based on extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over the past 5 years (2016-2020). The key players profiled in the global infectious disease diagnosis market are Abbott Laboratories (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux S.A. (France), Thermo Fisher Scientific (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Becton, Dickinson and Company (U.S.), DiaSorin S.p.A. (Italy), Meridian Bioscience Inc. (U.S.), and Quidel Corporation (U.S.).
Scope of the Report:
Infectious Disease Diagnostics Market by Product & Solution
Infectious Disease Diagnostics Market by Technology
Infectious Disease Diagnostics Market by Disease Type
Infectious Disease Diagnostics Market by End User
Infectious Disease Diagnostics Market by Geography
Key questions answered in the report-
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-Up Approach
2.3.1.2. Top-Down Approach
2.3.1.3. Growth forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Increasing Prevalence of Infectious Diseases
4.2.2. Growing Awareness of Early Disease Diagnosis
4.2.3. Impact of Covid-19
4.2.4. Rising Funds for Infectious Disease Diagnostics Research Activities
4.2.5. Shift in Focus from Centralized Laboratories to POC Testing Services
4.3. Restraints
4.3.1. Unfavorable and Inadequate Reimbursement Scenario
4.4. Opportunities
4.4.1. Advances in Genomics and Proteomics
4.4.2. Growing Awareness about Personalized Medicine
4.4.3. Emerging Economies
4.5. Challenges
4.5.1. Lack of Awareness of Specific Symptoms and Diagnosis of Emerging Infections
5. Global Infectious Disease Diagnostics Market, by Product & Service
5.1. Introduction
5.2. Consumables
5.3. Instruments
5.4. Software & Services
6. Global Infectious Disease Diagnostics Market, by Technology
6.1. Introduction
6.2. Immunodiagnostics
6.3. Clinical Microbiology
6.4. Polymerase Chain Reaction (PCR)
6.5. Isothermal Nucleic Acid Amplification Technology (INAAT)
6.6. DNA Sequencing and Next-Generation Sequencing (NGS)
6.7. DNA Microarray
6.8. Other Technologies
7. Global Infectious Disease Diagnostics Market, by Disease Type
7.1. Introduction
7.2. Hepatitis
7.3. Human Immunodeficiency Virus (HIV)
7.4. Hospital-Acquired Infections (HAIs)
7.5. Human Papillomavirus (HPV)
7.6. Tuberculosis (TB)
7.7. Influenza
7.8. Other Infectious Diseases
8. Global Infectious Disease Diagnostics Market, by End User
8.1. Introduction
8.2. Diagnostic Reference Laboratories
8.3. Hospital & Clinical Laboratories
8.4. Academic & Research Institutes
8.5. Other End Users
9. Infectious Disease Diagnostics Market, by Geography
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. Italy
9.3.3. France
9.3.4. U.K.
9.3.5. Spain
9.3.6. Rest of Europe (RoE)
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Rest of Asia-Pacific (RoAPAC)
9.5. Latin America
9.6. Middle East & Africa
10. Competitive Landscape
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Market Share Analysis (2019)
10.4.1. F. Hoffmann-La Roche Ltd.
10.4.2. Abbott Laboratories
10.4.3. Danaher Corporation
11. Company Profiles (Business Overview, Financial Overview, Product Portfolio and Strategic Developments)
11.1. Abbott Laboratories
11.2. Danaher Corporation
11.3. Bio-Rad Laboratories, Inc.
11.4. Biomérieux S.A.
11.5. F. Hoffmann-La Roche, Ltd.
11.6. Becton, Dickinson and Company
11.7. DiaSorin S.P.A.
11.8. Meridian Bioscience, Inc.
11.9. Quidel Corporation
11.10. Thermo Fisher Scientific, Inc.
12. Appendix
12.1. Questionnaire
12.2. Available Customization
List of Tables
Table 1 Global Infectious Disease Diagnostics Market Drivers: Impact Analysis (2020-2027)
Table 2 Covid 19 Confirmed Cases and Deaths across the World (2nd May 2020)
Table 3 Recent Diagnostic Tests Launched for Covid-19
Table 4 Global Infectious Disease Diagnostics Market Restraints: Impact Analysis (2020-2027)
Table 5 Clinical Applications of Infectious Disease Genomics and Proteomics
Table 6 Global Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
Table 7 Recent Launches and Approvals in the Consumables Market
Table 8 Key Companies offering Infectious Disease Diagnostic Consumables
Table 9 Global Infectious Disease Diagnostic Consumables Market Size, by Country/Region, 2018-2027 ($ Million)
Table 10 Key Companies offering Infectious Disease Diagnostic Instruments
Table 11 Global Infectious Disease Diagnostic Instruments Market Size, by Country/Region, 2018-2027 ($Million)
Table 12 Key Companies offering Infectious Disease Diagnostic Software and Services
Table 13 Global Infectious Disease Diagnostic Software & Services Market Size, by Country/Region, 2018-2027 ($ Million)
Table 14 Global Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($ Million)
Table 15 Key Companies offering Immunodiagnostic-Based Products
Table 16 Global Immunodiagnostic-Based Infectious Disease Diagnostics Market Size, by Country/Region, 2018-2027 ($ Million)
Table 17 Global Clinical Microbiology-Based Infectious Disease Diagnostics Market Size, by Country/Region, 2018-2027 ($Million)
Table 18 Key Companies offering PCR-Based Products
Table 19 Global PCR-Based Infectious Disease Diagnostics Market Size, by Country/Region, 2018-2027 ($Million)
Table 20 Global INAAT-Based Infectious Disease Diagnostics Market Size, by Country/Region, 2018-2027 ($Million)
Table 21 Global DNA Sequencing and NGS-Based Infectious Disease Diagnostics Market Size, by Country/Region, 2018-2027 ($Million)
Table 22 Global DNA Microarray-Based Infectious Disease Diagnostics Market Size, by Country/Region, 2018-2027 ($Million)
Table 23 Global Infectious Disease Diagnostics Market Size for Other Technologies, by Country/Region, 2018-2027 ($Million)
Table 24 Global Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
Table 25 Global Infectious Disease Diagnostics Market Size for Hepatitis, by Country/Region, 2018-2027 ($Million)
Table 26 Key Players offering HIV Diagnostic Products
Table 27 Global Infectious Disease Diagnostics Market Size for HIV, by Country/Region, 2018-2027 ($Million)
Table 28 Global Infectious Disease Diagnostics Market Size for HAIs, by Country/Region, 2018-2027 ($Million)
Table 29 Global Infectious Disease Diagnostics Market Size for HPV, by Country/Region, 2018-2027 ($Million)
Table 30 Global Infectious Disease Diagnostics Market Size for Tuberculosis, by Country/Region, 2018-2027 ($Million)
Table 31 Some of the FDA-Cleared Nucleic Acid Detection-Based Tests for Influenza (2019)
Table 32 Global Infectious Disease Diagnostics Market Size for Influenza, by Country, 2018-2027 ($Million)
Table 33 Covid 19 Confirmed Cases and Deaths across the World (2nd May 2020)
Table 34 Diagnostic Tests for Covid-19
Table 35 Global Infectious Disease Diagnostics Market Size for Other Infectious Diseases, by Country, 2018-2027 ($ Million)
Table 36 Global Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
Table 37 Global Infectious Disease Diagnostics Market Size for Diagnostic Reference Laboratories, by Country, 2017-2027 ($Million)
Table 38 Global Infectious Disease Diagnostics Market Size for Hospital & Clinical Laboratories, by Country, 2018-2027 ($ Million)
Table 39 Global Infectious Disease Diagnostics Market Size for Academic & Research Institutes, by Country, 2017-2027 ($Million)
Table 40 Global Infectious Disease Diagnostics Market Size for Other End Users, by Country, 2017-2027 ($Million)
Table 41 Global Infectious Disease Diagnostics Market Size, by Country/Region, 2018-2027 ($Million)
Table 42 North America: Infectious Disease Diagnostics Market Size, by Country, 2018-2027 ($Million)
Table 43 North America: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
Table 44 North America: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
Table 45 North America: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
Table 46 North America: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
Table 47 U.S.: Disease Rate and Number of New Cases (2016 & 2017)
Table 48 U.S.: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
Table 49 U.S.: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
Table 50 U.S.: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
Table 51 U.S.: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
Table 52 Canada: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
Table 53 Canada: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
Table 54 Canada: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
Table 55 Canada: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
Table 56 Europe: Infectious Disease Diagnostics Market Size, by Country, 2018-2027 ($Million)
Table 57 Europe: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
Table 58 Europe: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
Table 59 Europe: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
Table 60 Europe: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
Table 61 Germany: HIV and AIDS Estimates (2018)
Table 62 Personalized therapies Authorized in Germany (2017)
Table 63 Germany: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
Table 64 Germany: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
Table 65 Germany: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
Table 66 Germany: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
Table 67 Italy: Cancer Prevalence 2018
Table 68 Number of Cancer Cases, (2018 Vs 2040)
Table 69 Italy: Covid-19 Cases
Table 70 Italy: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
Table 71 Italy: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
Table 72 Italy: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
Table 73 Italy: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
Table 74 France: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
Table 75 France: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
Table 76 France: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
Table 77 France: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
Table 78 U.K.: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
Table 79 U.K.: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
Table 80 U.K.: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
Table 81 U.K.: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
Table 82 Spain: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
Table 83 Spain: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
Table 84 Spain: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
Table 85 Spain: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
Table 86 Hepatitis A Cases (2016 Vs.2017)
Table 87 Covid-19 Cases in European Countries
Table 88 Roe: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
Table 89 Roe: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
Table 90 Roe: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
Table 91 Roe: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
Table 92 Asia-Pacific: Infectious Disease Diagnostics Market Size, by Country, 2018-2027 ($Million)
Table 93 Asia-Pacific: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
Table 94 Asia-Pacific: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
Table 95 Asia-Pacific: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
Table 96 Asia-Pacific: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
Table 97 Japan: Percentage Geriatric Population (65 and Over)
Table 98 Japan: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
Table 99 Japan: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
Table 100 Japan: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
Table 101 Japan: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
Table 102 China: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
Table 103 China: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
Table 104 China: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
Table 105 China: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
Table 106 India: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
Table 107 India: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
Table 108 India: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
Table 109 India: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
Table 110 RoAPAC: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
Table 111 RoAPAC: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
Table 112 RoAPAC: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
Table 113 RoAPAC: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
Table 114 Latin America: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
Table 115 Latin America: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
Table 116 Latin America: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
Table 117 Latin America: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
Table 118 EDCTP Funding for Infectious Disease Diagnostics (2003-2018)
Table 119 Middle East & Africa: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
Table 120 Middle East & Africa: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
Table 121 Middle East & Africa: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
Table 122 Middle East & Africa: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
Table 123 Recent Developments, by Company, 2017-2020
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Size Estimation
Figure 7 Global Infectious Disease Diagnostics Market, by Product & Service, 2020 Vs. 2027 ($Million)
Figure 8 Global Infectious Disease Diagnostics Market Size, by Technology, 2020 Vs. 2027 ($Million)
Figure 9 Global Infectious Disease Diagnostics Market Size, by Disease Type, 2020 Vs. 2027 ($Million)
Figure 10 Diagnostic Reference Laboratories Are Expected to Dominate the Global Infectious Disease Diagnostics Market, by End User (2020-2027)
Figure 11 Infectious Disease Diagnostics Market, by Region
Figure 12 Market Dynamics
Figure 13 Global Infectious Disease Diagnostics Market Size, by Product & Service, 2020-2027 ($Million)
Figure 14 Global Infectious Disease Diagnostics Market Size, by Technology, 2020-2027 ($Million)
Figure 15 Global Infectious Disease Diagnostics Market Size, by Disease Type, 2020-2027 ($Million)
Figure 16 U.S.: Hospital-Acquired Infections
Figure 17 Tuberculosis R&D Funding (2015-2018)
Figure 18 Laboratory Confirmed Hospitalization Rate for Influenza, 2019-2020
Figure 19 Global Infectious Disease Diagnostics Market Size, by End User, 2020-2027 ($Million)
Figure 20 Tuberculosis R&D Funding (2015-2018)
Figure 21 Global Infectious Disease Diagnostics Market Size, by Geography, 2020-2027 ($Million)
Figure 22 North America: Infectious Disease Diagnostics Market Snapshot
Figure 23 U.S. Health Expenditure for Homecare Settings (2005-2017) (in $Billion)
Figure 24 Europe: Infectious Disease Diagnostics Market Snapshot
Figure 25 Germany: Infection Data, by Infection Site, 2010-2016 (%)
Figure 26 France: Percentage of Older People (65 Years and Above), 2010-2050
Figure 27 Asia-Pacific: Infectious Disease Diagnostics Market Snapshot
Figure 28 China: Geriatric Population (Million)
Figure 29 Coronavirus Outbreak in Latin America (6th May 2020)
Figure 30 Healthcare Expenditure in Latin America (2012-2016)
Figure 31 Key Growth Strategies Adopted by Leading Players, 2017-2020
Figure 32 Infectious Disease Diagnostics: Competitive Benchmarking
Figure 33 Market Share Analysis: Infectious Disease Diagnostics Industry, 2019
Figure 34 Abbott Laboratories: Financial Overview (2019)
Figure 35 Danaher Corporation: Financial Overview (2019)
Figure 36 Bio-Rad Laboratories, Inc.: Financial Overview (2019)
Figure 37 Biomérieux S.A.: Financial Overview (2018)
Figure 38 F. Hoffmann-La Roche, Ltd.: Financial Overview (2019)
Figure 39 Becton, Dickinson and Company: Financial Overview (2019)
Figure 40 DiaSorin S.P.A.: Financial Overview (2018)
Figure 41 Meridian Bioscience, Inc.: Financial Overview (2019)
Figure 42 Quidel Corporation: Financial Overview (2019)
Figure 43 Thermo Fisher Scientific, Inc.: Financial Overview (2019)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Jan-2023
Published Date: Oct-2022
Published Date: Jun-2022
Published Date: May-2022
